Therorna
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- $42M
Investors
- 6
About Therorna
, Ltd. operates as a biotechnology company that focuses on the research and application of circular RNA technology in the field of innovative drugs and therapeutics. The company's founder, Wei Wensheng, is the director of Peking University's Genome Editing Research Center. The company's CEO, Daniel Tang, was the COO of Vanshi Biomedical., Ltd. The company focuses on developing new vaccines and innovative therapies by using circular RNA technology. The company will focus on the pre-clinical and clinical studies for new drug pipelines.
Who invested in Therorna
6 investors across 2 rounds
See all investors in Therorna
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Therorna
Who invested in Therorna?
Therorna has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Therorna raised?
Therorna has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Therorna last raise money?
Therorna's most recent round on record is a Series A, in Jun 2022.
What does Therorna do?
Therorna is a biotechnology company.
Where is Therorna headquartered?
Therorna is headquartered in Beijing, China.
Which VCs invest in companies like Therorna?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Therorna's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Therorna? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.